Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting PressReach · Nov 9, 2024
'ESSE' Maker KT&G Expands Presence in Europe with Romania Entry, Achieving Record-Breaking Overseas Sales in Q3 PressReach · Nov 8, 2024
TEZSPIRE MET BOTH CO-PRIMARY ENDPOINTS IN PHASE 3 TRIAL FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS PressReach · Nov 8, 2024
Harbour BioMed Announces Submission of IND Application for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease PressReach · Nov 8, 2024
MGI Tech Partners with the Human Cell Atlas to Further Advance Worldwide Human Cell Mapping Efforts PressReach · Nov 7, 2024
Enzymatica AB's Interim report Q3/2024: Focus on developing existing and new markets PressReach · Nov 7, 2024
ARTHEx Biotech Announces FDA Rare Pediatric Designation (RPD) of ATX-01 for the Treatment of Myotonic Dystrophy Type 1 (DM1) PressReach · Nov 7, 2024
In-depth analysis showing robust Diamyd® treatment effects across clinical trials to be shared at the 2024 IDS Diabetes Congress PressReach · Nov 6, 2024
CROWN AESTHETICS PROVIDES CAVENDISH CLINICS WITH AWARD-WINNING SKINPEN® PRECISION TO UPGRADE ITS MICRONEEDLING DEVICE OFFERING PressReach · Nov 6, 2024
So-Young to Report Third Quarter 2024 Financial Results on November 20, 2024 PressReach · Nov 6, 2024
